PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-35.79%
Cash & equivalents declining -35.79% while RVPH's grows 26.23%. Howard Marks would question why our liquidity is shrinking while competitor builds cash.
No Data
No Data available this quarter, please select a different quarter.
-35.79%
Below half of RVPH's 26.23%. Michael Burry might suspect a liquidity shortfall if there's no alternative capital plan.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-31.27%
Other current assets growth < half of RVPH's -100.00%. David Dodd sees a leaner approach to short-term items.
-32.53%
Below half of RVPH's 13.05%. Michael Burry could suspect a liquidity squeeze. Verify operational performance.
-2.15%
Both RVPH and the company show zero PP&E (Net) Growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.04%
Less than half of RVPH's -99.96%. David Dodd sees fewer expansions in non-core assets. Possibly a simpler focus.
-1.56%
Below half of RVPH's -99.96%. Michael Burry might suspect stagnation or lack of resources for expansions.
No Data
No Data available this quarter, please select a different quarter.
-28.33%
Below half of RVPH's -99.70%. Michael Burry sees a potential red flag for stagnation or capital shortage.
-12.11%
Higher Accounts Payable Growth compared to RVPH's zero value, indicating worse performance.
-29.66%
Higher Short-Term Debt Growth compared to RVPH's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
6.29%
Higher Deferred Revenue (Current) Growth compared to RVPH's zero value, indicating better performance.
100.00%
Exceeding 1.5x RVPH's 0.64%. Michael Burry suspects ballooning short-term obligations vs. competitor.
-11.86%
Less than half of RVPH's 7649.26%. David Dodd sees a more disciplined short-term liability approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Similar yoy changes to RVPH's -100.00%. Walter Schloss sees parallel expansions in other LT liabilities.
-7.08%
Less than half of RVPH's -100.00%. David Dodd sees a more conservative approach to non-current liabilities.
No Data
No Data available this quarter, please select a different quarter.
-11.32%
Less than half of RVPH's 235.25%. David Dodd sees far fewer liability expansions relative to competitor.
6.25%
Less than half of RVPH's -100.00%. David Dodd sees fewer share issuances vs. competitor.
-2.72%
Below half RVPH's -4275.89%. Michael Burry suspects major net losses or high dividends vs. competitor.
100.00%
Higher AOCI Growth compared to RVPH's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
-46.50%
Below half RVPH's 1055.17%. Michael Burry sees potential underperformance in building shareholder capital.
-28.33%
Below half RVPH's -97.31%. Michael Burry sees significant shrinkage or inactivity vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
-8.76%
Higher Total Debt Growth compared to RVPH's zero value, indicating worse performance.
40.72%
Less than half of RVPH's 2948.35%. David Dodd sees better deleveraging or stronger cash buildup than competitor.